Kinetik Holdings Inc. <KNTK.N>: Citigroup raises target price to $55 from $52
KNTK•Related News
C4 Therapeutics Q2 EPS USD -0.18 Vs. IBES Estimate USD -0.23
CCCC•
Harvard Bioscience Q2 FY26 net loss widens to $2.9 million; revenue rises 11% to $22.7 million
HBIO•
Phio Pharma wins U.S. patent allowance for BRD4-targeting INTASYL compound PH-894
PHIO•
Best Buy Co., Inc. <BBY.N>: Truist Securities raises to Buy from Hold; raises target price to $95 from $81
BBY•
SunHydrogen modules exceed 10% solar-to-hydrogen efficiency in Sparc Hydrogen testing
HYSR•